Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

Fonte: Business Insider

People with diabetes lost an average of nearly 20 pounds of body weight during a clinical trial of orforglipron, which is a new small molecule GLP-1 drug. colnihko/Getty ImagesEli Lilly's new GLP-1 pill surged ahead of competitor Novo Nordisk's in a head-to-head trial. Patients on Lilly's pill had better blood sugar levels, lost more weight, and improved heart health.